Bacterial Vaginosis Male Partner Treatment - Breakfast Session
Speakers:
Anna Powell, MD (Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine) & Golsa Yazdy, MD (Johns Hopkins School of Medicine)
Moderators:
Jennifer Balkus, PhD (University of Washington) & Christina Muzny, MD, MSPH (Department of Medicine | Division of Infectious Diseases - Heersink School of Medicine | University of Alabama at Birmingham)
7:30 AM - 8:30 AM
Harbor 1
Breakfast
9:00 AM - 10:15 AM
Harbor 3&4
General Session 1
9:00 AM - 10:15 AM
Sexually Transmitted Infections: Management and Prevention Challenges
Speaker:
Kimberly A. Workowski, MD (Professor of Medicine, Division of Infectious Diseases, Emory University)
10:15 AM - 10:45 AM
Break
10:45 AM - 11:45 AM
Harbor 3&4
Oral Abstract Session 1
10:45 AM - 11:00 AM
Microbiome-mediated proteolytic activation of complement C3 as a putative pathway to preterm birth (#001)
Speaker:
Laura Sycuro (University of Calgary)
11:00 AM - 11:15 AM
A Cervical Microphysiologic Model Incorporating Immunologic Properties of Sexually Transmitted Infections (#002)
Speaker:
Katherine Nelson (University of Delaware)
11:15 AM - 11:30 AM
AI-Based Detection of Intra-amniotic Infection Enables Earlier Diagnosis and Identifies Subclinical Histological Disease (#003)
Speaker:
Nima Aghaeepour (Stanford University)
11:30 AM - 11:45 AM
Compartment-Specific Inflammatory and Protease-Related Profiles in Preterm Birth in Pregnancies Affected by HIV (#004)
Speaker:
Jacqueline Corry (The Ohio State University)
11:45 AM - 12:00 PM
240 West Restaurant
Break - grab lunch
12:00 PM - 1:00 PM
Harbor 3&4
Industry Sponsored Symposium 1
1:00 PM - 2:15 PM
Harbor 2
Poster Session 1
1:00 PM - 2:15 PM
Interferon Gamma Responses to Tuberculosis Antigen in IGRA Positive Women with and without HIV: a PRACHITi Cohort Analysis (#027)
Speaker:
Spencer Darveau (NewYork-Presbyterian Weill Cornell Medicine, Department of Ob/Gyn, New York, New York, USA)
1:00 PM - 2:15 PM
Do State Vaccine Policies Influence Infant Infectious Mortality? A Population-Based Analysis, 2017–2022 (#028)
Speaker:
Diana Toro (UT Health San Antonio)
1:00 PM - 2:15 PM
Efficacy and cytotoxicity of MB-14-1-15, a microbicide to prevent Neisseria gonorrhoeae infections (#029)
Speaker:
Joseph Dillard (University of Wisconsin-Madison)
1:00 PM - 2:15 PM
CD4+ and CD8+ T-cell miRNA profiles associated with Chlamydia trachomatis reinfection risk (#031)
Speaker:
Chloe Meewes (Department of Medicine, University of Alabama at Birmingham)
1:00 PM - 2:15 PM
Severe Maternal Morbidity and Mortality in Pregnant People with Chronic Hepatitis C and Substance Use: Findings from the stOrc hiSToRIcal CoHort (OSTRICH) Study, a Multicenter North American Cohort (#032)
Speaker:
Jasmin Charles (University of Utah)
1:00 PM - 2:15 PM
Comparative Analysis of Neonatal Outcomes After Maternal Treatment of Intraamniotic Infection with Ceftriaxone–Metronidazole or Ampicillin–Gentamicin (#033)
Speaker:
Chelsea Zhang (Duke University School of Medicine)
1:00 PM - 2:15 PM
Acceptability of STI Testing and HIV PrEP Co-Delivery in Pharmacies for Adolescent Girls and Young Women in Kenya (#034)
Speaker:
Omolara Akingba (University of Washington)
1:00 PM - 2:15 PM
Incident Vulvovaginal Candidiasis in Women Initiating Sodium Glucose Transport Protein 2 Inhibitors (#035)
Speaker:
Ayesha Khan (Massachusetts General Hospital)
1:00 PM - 2:15 PM
Maternal RSV Vaccination Messaging: An Analysis of Patient-Facing Web-Based Informatics Using Automated Data Extraction (#036)
Speaker:
Marta Langley (Corewell Health West)
1:00 PM - 2:15 PM
Association of Inflammatory Cytokine Profiles with Preterm Birth Differs by HIV Status (#037)
Speaker:
Stephanie Fisher (Northwestern University Feinberg School of Medicine)
1:00 PM - 2:15 PM
Beyond the Prenatal Visit: Identifying Health System Opportunities to Improve the Diagnosis and Treatment of Maternal Syphilis (#038)
Speaker:
Claudia Nieuwoudt (Prisma Health/University of South Carolina School of Medicine Greenville)
1:00 PM - 2:15 PM
Hepatitis B Vaccination Following Implementation of a Triple-Panel Screening Initiative in Obstetric Clinics (#039)
Speaker:
Natasha Anders (Duke University School of Medicine)
1:00 PM - 2:15 PM
Influence of HIV status on healthcare utilization patterns and predictors of pregnancy-related comorbidities among pregnant people living in Malawi (#040)
Speaker:
Cassandra Seifert (UPMC Magee-Womens Hospital, Department of Obstetrics and Gynecology)
1:00 PM - 2:15 PM
Closing the Gap: Faster Wound Resolution After Cesarean Surgical Site Infection With Repeat Primary Closure (#041)
Speaker:
Mary Silzer (Duke University School of Medicine)
1:00 PM - 2:15 PM
Patient-Reported Severity and Impact of Vaginitis Symptoms on Daily Functioning (#042)
Speaker:
Sharon L. Hillier (Magee-Womens Research Institute; University of Pittsburgh)
1:00 PM - 2:15 PM
Hepatitis B Screening in Pregnancy After Updated Screening Recommendations: A Quality Improvement Study (#043)
Speaker:
Sara Bernate Angulo (Duke University School of Medicine)
1:00 PM - 2:15 PM
PrEP Eligibility and Initiation among Patients in a Title IX Reproductive Health Clinic (#044)
Speaker:
Anne Bocage (Thomas Jefferson University Hospital)
1:00 PM - 2:15 PM
Prevalence and Pathophysiology of Amenorrhea Among Women Survivors of the 2014–2016 Ebola Outbreak in Sierra Leone (#045)
Speaker:
Crystal Zheng (Tulane University)
1:00 PM - 2:15 PM
Severe Maternal Morbidity and Mortality in Pregnant Individuals with Chronic Hepatitis C: Findings from the stOrc hiSToRIcal CoHort (OSTRICH) Study, a Multicenter North American Cohort (#056)
Speaker:
Marcela Smid (University of Utah)
1:00 PM - 2:15 PM
Evaluating HPV Vaccine Literacy and Perceptions Among Immigrant Populations in Middlesex County, New Jersey (#047)
Speaker:
Riddhi Jadhav (Rutgers Robert Wood Johnson Medical School)
1:00 PM - 2:15 PM
Strain specific effects of Trichomonas vaginalis exosomes on interferon epis (#048)
When Surgical Complications Meet Mental Health: Risk Factors for Postpartum Depression in Patients with Cesarean Wound Infections (#049)
Speaker:
Olivia Fehrmann (Duke University School of Medicine)
1:00 PM - 2:15 PM
Running Versus Interrupted Subcutaneous Closure Among Patients Who Develop Cesarean Surgical Site Infections (#050)
Speaker:
Lillian Boettcher (Duke University Division of Maternal-Fetal Medicine)
1:00 PM - 2:15 PM
Clinical Performance of the Alinity m BV Assay Across Five U.S. Sites (#051)
Speaker:
Danijela Lucic (Molecular Dx of Abbott)
1:00 PM - 2:15 PM
Adherence to Syndromic Vaginitis Management Guidelines in Routine Antenatal Care in Kenya (#052)
Speaker:
Zoe Bischoff (University of Washington)
1:00 PM - 2:15 PM
Retrospective Evaluation of Adherence to Diagnostic Criteria for Postpartum Endometritis in Clinical Practice (#053)
Speaker:
Maria Cristina Marcos (Thomas Jefferson University Hospital)
1:00 PM - 2:15 PM
Rethinking Antibiotic Therapy for Intraamniotic Infection at Cesarean Delivery in the Era of Ampicillin Resistance (#054)
Speaker:
Andrea Gorodezky (Duke University School of Medicine)
1:00 PM - 2:15 PM
Vaccine-Specific Factors Influencing Prenatal Tetanus, Diphtheria, and Acellular Pertussis (Tdap), COVID-19, and Influenza Vaccine Refusal (#055)
Speaker:
Mary Mitchener (Wake Forest University School of Medicine)
2:15 PM - 3:30 PM
Harbor 3&4
Oral Abstract Session 2
2:15 PM - 2:30 PM
Selective Human-Milk-Inspired Antimicrobial Peptides for the Treatment of Bacterial Vaginosis (#005)
Speaker:
Ishita Shah (Matrubials Inc.)
2:30 PM - 2:45 PM
Microbiome-Defined BV Subtypes Are Associated With Distinct Recurrence Burden Among Participants Meeting Standard BV Criteria (#006)
Speaker:
Rob Markowitz (Evvy)
2:45 PM - 3:00 PM
Boric Acid Impairs Lactobacillus crispatus Growth and Lactic Acid Production (#007)
Speaker:
Piper Kinney (Vincent Center for Reproductive Biology, Massachusetts General Hospital and Simmons Univeristy)
3:00 PM - 3:15 PM
The Role of Lactobacillus iners Dominated Vaginal Microbiota and Sexual Activity in Incident Bacterial Vaginosis Pathogenesis (#008)
Speaker:
Christopher M. Taylor (Department of Microbiology, Immunology, and Parasitology/Louisiana State University Health Sciences Center - New Orleans)
3:15 PM - 3:30 PM
In vitro Activity of a Novel Ozonated Oil Formulation Against Isolates of Trichomonas vaginalis (#009)
Speaker:
Keonte Graves (Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham)
5:00 PM - 6:30 PM
Welcome Reception
Friday, July 17, 2026
7:30 AM - 8:30 AM
Harbor 1
Breakfast
7:30 AM - 8:30 AM
Harbor 3&4
Annual Business Meeting
8:30 AM - 9:30 AM
Harbor 3&4
General Session 2
8:30 AM - 9:30 AM
Controversies Surrounding the Hepatitis B Vaccine for Newborns
Speaker:
Paul A. Offit, MD (Director, Vaccine Education Center, Children’s Hospital of Philadelphia; Maurice R. Hilleman Professor of Vaccinology, University of Pennsylvania School of Medicine)
9:30 AM - 10:00 AM
Break
10:00 AM - 11:00 AM
Harbor 3&4
Oral Abstract Session 3
10:00 AM - 10:15 AM
Sneathia Species Reprogram Cervical Epithelial Metabolism: Insights from a 3D Human Model (#010)
Speaker:
Pawel Laniewski (University of Arizona)
10:15 AM - 10:30 AM
Vaginal Washing is Associated With Transcriptomic Changes in Cervical Immune Cells (#011)
Speaker:
Aidan Shev (University of Washington)
10:30 AM - 10:45 AM
Sneathia vaginalis Induces Release of Damage-Associated Proteins in an Ex Vivo Amnion Model (#012)
Speaker:
Kimberly Jefferson (Virginia Commonwealth University)
10:45 AM - 11:00 AM
Discovering Novel and Understudied Bacteria in the Upper Reproductive Tract Through Integrated Culturomics and Genome Sequencing (#013)
Speaker:
Nicole Jimenez (University of Arizona- College of Medicine-Phoenix)
11:00 AM - 12:15 PM
Harbor 2
Poster Session 2
11:00 AM - 12:15 PM
Transition to Ceftriaxone–Metronidazole for Intraamniotic Infection and Postpartum Infection Risk After Vaginal Birth (#056)
Speaker:
Chelsea Zhang (Duke University School of Medicine)
11:00 AM - 12:15 PM
HIV During Pregnancy and Risk of Miscarriage Among Women Who Engage in Sex Work in Mombasa, Kenya (#057)
Speaker:
Hanna Shephard (University of Washington; Pwani Research Centre)
11:00 AM - 12:15 PM
Complications Beyond the Incision: Breastfeeding Outcomes after Cesarean Site Infection (#058)
Speaker:
Olivia Fehrmann (Duke University School of Medicine)
11:00 AM - 12:15 PM
Impact of HIV on HPV-associated Cancers in Women in a Southern State (#059)
Speaker:
Britton Gibson (MUSC)
11:00 AM - 12:15 PM
Hepatitis C Virus Detection Before or During Pregnancy After Universal Screening Recommendation (#060)
Speaker:
Priyanka Gaur (Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Weill Cornell Medicine)
11:00 AM - 12:15 PM
Decreased Risk of Incident Trichomonas vaginalis with Hormonal Contraception Use in Adolescent Girls: A Secondary Analysis from a Randomized Trial (#061)
Speaker:
Marisa R Young (Emory University)
11:00 AM - 12:15 PM
Views and experiences of Family Medicine and OBGYN providers regarding adult HPV vaccination: Findings from a mixed methods study. (#062)
Speaker:
Jill M. Maples (The University of Tennessee Health Science Center College of Medicine Knoxville)
11:00 AM - 12:15 PM
From ‘Should I Ask?’ to Standard of Care: Normalizing Pre-exposure Prophylaxis Conversations in Gynecology (#063)
Speaker:
Jayelin Parker (University of Michigan Medical School, Department of Obstetrics and Gynecology)
11:00 AM - 12:15 PM
Early Spontaneous Clearance of T. vaginalis Among Men and Women (#064)
Speaker:
Patricia Kissinger (Tulane University School of Public Health and Tropical Medicine)
11:00 AM - 12:15 PM
Clinical Performance of the Alinity m CV/TV Assay for Detection of Candida spp. and Trichomonas vaginalis (#065)
Speaker:
Danijela Lucic (Molecular Dx of Abbott)
11:00 AM - 12:15 PM
Association Between Time to Antibiotic Administration and ICU Admission in Pregnant Persons With Sepsis (#066)
Speaker:
Jacqueline Moreno (University of Texas Health Science Center San Antonio)
11:00 AM - 12:15 PM
Evaluation of a Novel Point-of-Care Test for the Diagnosis of Bacterial Vaginosis: Comparison with an FDA-Cleared Molecular Assay (#067)
Speaker:
Monica Koubeck (Nanopath)
11:00 AM - 12:15 PM
Sialidase Detection of Frozen Vaginal Specimens Stored in Phosphate Buffered Saline With or Without DNA Preservative (#068)
Speaker:
Sheridan George (University of Alabama at Birmingham)
11:00 AM - 12:15 PM
Provider Feedback on a Decision Aid on Infant Feeding for Pregnant People Living with HIV (#069)
Speaker:
Celeste Coler (University of Washington School of Medicine)
11:00 AM - 12:15 PM
The Aftermath of Obstetric Anal Sphincter Injury: Antibiotic Prophylaxis and Incidence of Infectious Wound Complication at an Academic Health System (#070)
Speaker:
Katharina Goebel (Emory University School of Medicine)
11:00 AM - 12:15 PM
Syphilis in Pregnancy and Congenital Syphilis in British Columbia, Canada from 2015-2025. (#071)
Speaker:
Deborah Money (University of British Columbia)
11:00 AM - 12:15 PM
Clinical Outcome at One Year Post-Treatment of Human Papilloma Virus among Female Sex Workers in Cameroon (#072)
Speaker:
Simon Manga (University of Alabama at Birmingham)
11:00 AM - 12:15 PM
Off the Radar: Low Awareness of Mycoplasma genitalium Among Adolescents and Young Adults Despite High STI Burden (#073)
Speaker:
Theresa Rager (University of Michigan)
11:00 AM - 12:15 PM
Outpatient Antibiotic Treatment Regimens of Cesarean Surgical Site Infections (#074)
Speaker:
Lillian Boettcher (Duke University Division of Maternal-Fetal Medicine)
11:00 AM - 12:15 PM
Improving Peri-operative Antibiotic Management at the Time of Cesarean Delivery to Reduce Surgical Site Infections in Women with Severe Postpartum Hemorrhage at a Single Institution (#075)
Speaker:
Ansley Parker-Hurley (University of Tennessee Medical Center)
11:00 AM - 12:15 PM
Prospective Cohort Study of the Association between Periconceptual Infection with Mycoplasma genitalium and Preterm Birth (#076)
Speaker:
Nathaniel Sisson (University of Washington)
11:00 AM - 12:15 PM
PrEP4Her: A Mixed Methods Study Exploring Gynecology Providers’ Acceptability and Feasibility Delivering a Clinic-Based PrEP Intervention to Women in the Southeastern United States (#077)
Speaker:
Anais T. Mahone (Division of Infectious Diseases, Department of Medicine, Heersink School of Medicine, University of Alabama at Birmingham)
11:00 AM - 12:15 PM
The Effect of Multiple Provider Recommendations on Tetanus, Diphtheria, and Acellular Pertussis (Tdap) Vaccination in Pregnancy (#078)
Speaker:
Mary Mitchener (Wake Forest University School of Medicine)
11:00 AM - 12:15 PM
Fannyhessea Vaginae as a Dominant Algorithmic Feature for Molecular Bacterial Vaginosis Classification: Evidence from Constrained and Unconstrained Decision Tree Models (#079)
Speaker:
Devon Essick (bioMérieux SA)
11:00 AM - 12:15 PM
Trends in Chlamydia trachomatis, Neisseria gonorrhoeae and Pelvic Inflammatory Disease Diagnosis among King County, Washington Residents Enrolled in Medicaid, 2016-2024 (#080)
Speaker:
Christina S. Thibault (Public Health - Seattle & King County)
11:00 AM - 12:15 PM
Successful Treatment of Resistant Trichomonas Vaginalis with Combination Tinidazole and Paromomycin (#081)
Speaker:
Karley Dutra (Thomas Jefferson University Hospital)
Speaker:
Haben Debessai (Emory University SOM, Dept of Gynecology and Obstetrics)
11:00 AM - 12:15 PM
A retrospective cohort study: Is there an association between chorioamnionitis and type of diabetes mellitus in pregnancy? (#083)
Speaker:
Annie Addison (University of Tennessee Knoxville Medical Center)
11:00 AM - 12:15 PM
Navigating Sexual Health Conversations with Transgender Men: Challenges and Solutions from Health Care Providers in the Transgender Men’s Health, Experiences, and Responses to Testosterone (T-HEART) Study (#084)
Speaker:
Carly Duncan (Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL, USA)
12:15 PM - 12:30 PM
240 West Restaurant
Break - grab lunch
12:30 PM - 1:30 PM
Harbor 3&4
Industry Sponsored Symposium 2
1:30 PM - 2:45 PM
Harbor 3&4
Oral Abstract Session 4
1:30 PM - 1:45 PM
A Twelvefold Increase: Congenital Syphilis in Texas Dramatically Outpaces Adult Syphilis Trends (#014)
Speaker:
Diana Toro (UT Health San Antonio)
1:45 PM - 2:00 PM
Transient Increase in HIV Susceptibility Detected Immediately Following Levonorgestrel-releasing Intrauterine System Insertion (#015)
Speaker:
Katherine Bunge (University of Pittsburgh)
2:00 PM - 2:15 PM
The Other Half of the Equation: Engaging Sexual Partners in HIV Prevention and Pre-Exposure Prophylaxis (PrEP) Uptake in Obstetric and Gynecologic Care (#016)
Speaker:
Prisha Batra (Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine)
2:15 PM - 2:30 PM
Universal Syphilis Screening Leads to Improved Adherence and Timely Treatment (#017)
Speaker:
Megan Nocita (Department of OB/GYN, Vanderbilt)
2:30 PM - 2:45 PM
Dengue Among Pregnant and Non-Pregnant Patients in Puerto Rico 2019–2025 (#018)
Speaker:
Emily Trautner (Centers for Disease Control and Prevention)
2:45 PM - 3:15 PM
Harbor 3&4
MINA project Vaccines MINA-Lot: Key Findings from SMFM’s Maternal Immunization Needs Assessment Project
Speakers:
Syeda Lamiya Ahmed (Manager, Public Health Initiatives Department, Society for Maternal-Fetal Medicine (SMFM)), Haben Debessai (Emory University SOM, Dept of Gynecology and Obstetrics) & Kimberly B. Fortner, MD, FACOG (The University of Tennessee - Knoxville)
7:00 PM - 11:00 PM
Awards Ceremony
Saturday, July 18, 2026
7:30 AM - 8:30 AM
Waterfront Restaurant
Breakfast
8:30 AM - 9:30 AM
Harbor 3&4
General Session 3
8:30 AM - 9:30 AM
Test and Treat Hepatitis C Virus in Pregnancy: Are We There Yet?
Speaker:
Catherine Chappell, MD, MSc (Associate Professor, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh)
9:30 AM - 10:30 AM
Harbor 3&4
Stump the Professor
9:30 AM - 9:50 AM
Case 1 - The Masquerade in the Mesentery
Speaker:
Daniel Amran (UT Health San Antonio)
9:50 AM - 10:10 AM
Case 2 - Home Birth, Hospital Outcome A Case of Postpartum Crisis
Speaker:
Nicole Boland (The University of Tennessee - Knoxville)